AspenBio Pharma (APPY)
AspenBio Pharma Market Cap: 5.971M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
APPY Market Cap Rankings
| Overall | 1st percentile | 4596 of 4649 |
| Sector | 1st percentile | 519 of 525 in Healthcare |
| Industry | 0th percentile | 18 of 18 in Diagnostic Substances |
APPY Market Cap Range, Past 5 Years
| Minimum | 5.971M | May 25 2012 |
| Maximum | 270.20M | Sep 2007 |
| Average | 93.06M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these APPY related companies
APPY News
$APPY filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3H0d
about 48 days ago by MarketBrief
about 48 days ago by MarketBrief
AspenBio Pharma (APPY) Presents Encouraging Data for AppyScore from 503-Patient Pilot Study
Mar 16, 2:17PM Street Insider
Mar 16, 2:17PM Street Insider
Canaccord Genuity Maintains a 'Hold' on AspenBio Pharma (APPY); Not Losing Sight of Big Picture
Feb 22, 10:21AM Street Insider
Feb 22, 10:21AM Street Insider
Canaccord Genuity Maintains a 'Hold' on AspenBio Pharma (AAPY); Multi-marker Panel Likely Key to Approval & Uptake
Jan 24, 8:52AM Street Insider
Jan 24, 8:52AM Street Insider
$APPY Announces Registered Direct Offering of Approximately $1.6 Million
about 152 days ago by Benzinga
about 152 days ago by Benzinga
AspenBio Pharma reports data from AppyScore pilot and planned product pathway
Nov 28, 4:18PM FlyOnTheWall
Nov 28, 4:18PM FlyOnTheWall
AspenBio Reports Data From AppyScore Pilot Study and Planned Product Pathway
Nov 28, 4:15PM Benzinga
Nov 28, 4:15PM Benzinga
AspenBio Reports Interim Data From AppyScore Pilot Study and Outlook for Regulatory Pathway
Oct 19, 4:05PM Marketwire
Oct 19, 4:05PM Marketwire
AspenBio Pharma to Hold Investor Update Call on Wednesday, October 19, 2011 at 4:30 p.m. ET
Oct 17, 6:25PM Marketwire
Oct 17, 6:25PM Marketwire
$APPY $0.75 Mkt Cap $30,103,740 offering $15,000,000 (50% dilution) in common shs, warrants
about 379 days ago by canarionyc
about 379 days ago by canarionyc
Content with holding $urg under 3. $appy is holding up nicely, looking to have another bite in the morning.
about 494 days ago by CRPowers
about 494 days ago by CRPowers
Another bite of $appy .6295 for a .675 avg. I like the way it is holding above .60
about 494 days ago by CRPowers
about 494 days ago by CRPowers
@mb_willoughby @wibiya Nice post MB. Like the looks of $APPY tomorrow. Great find. $$
about 495 days ago by kidspouseme
about 495 days ago by kidspouseme
$APPY: the fun appears to be over. whoever got out, got out. 5 million shares traded. Insider victory party in Castle Rock tonight. lol.
about 579 days ago by BiotechtraderHB
about 579 days ago by BiotechtraderHB
$APPY: back from the dead? big volume again. news on appyscore -- be careful with this one...
about 579 days ago by BiotechtraderHB
about 579 days ago by BiotechtraderHB
Congrats to those that played $APPY today from last nights Alert. 50% Gain! Low of .35 closing hod at .57 http://bit.ly/dfJ5NO $$
about 580 days ago by ManicTrader
about 580 days ago by ManicTrader
$APPY http://chart.ly/q5urrdq Picks to Radar~ $APPY Aspen bio pharma Looking sweet
about 581 days ago by ManicTrader
about 581 days ago by ManicTrader
@DigDugTrader FYI Michael Vlaicu is a penny stock promoter $FAZ $APPY
about 657 days ago by j_remington
about 657 days ago by j_remington
I had some fun w. $APPY and its penchant for making excuses to explain clinical trial blowups --> http://bit.ly/aIgwhI
about 677 days ago by adamfeuerstein
about 677 days ago by adamfeuerstein
this morning started small positions $ANV 19.33 $AAPL 257.59 $ISLN 14.59 $APPY 3.59
about 740 days ago by CumbucoTrader
about 740 days ago by CumbucoTrader
Meant $ACAS, NOT $APPY: Nice buying opp on $APPY this AM on the dip below $6 considering earnings and JPMorgan upgrade. NAV is tickling $9
about 753 days ago by wesleydrake30
about 753 days ago by wesleydrake30
Nice buying opp on $APPY this AM on the dip below $6 considering solid earnings and JPMorgan upgrade. NAV is tickling $9
about 753 days ago by wesleydrake30
about 753 days ago by wesleydrake30
$APPY Sold June 2.50 puts @ .45 bought at .35. A decent gain...still think it has more room to go to 3.25
about 754 days ago by silviaracer
about 754 days ago by silviaracer
SELLING entire $APPY position Monday. Taking profits to POZN. Staying LONG & ADDING more to POZN Monday Pre-Market. POZN Received Approval!
about 757 days ago by FloridaGators
about 757 days ago by FloridaGators
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| APPY | 0.62 | -0.02 | -3.12% | 5.971M |
| APP | 0.8505 | -0.01 | -1.68% | 89.86M |
| APOL | 33.12 | +0.61 | +1.88% | 4.170B |
| APOG | 14.97 | -0.02 | -0.13% | 419.46M |
| AON | 47.39 | +0.04 | +0.08% | 15.41B |
| AOL | 27.48 | -0.13 | -0.47% | 2.605B |
| ANX | 0.535 | -0.01 | -0.93% | 25.53M |
| ANW | 5.27 | +0.01 | +0.19% | 243.63M |
| ANV | 27.47 | -0.20 | -0.72% | 2.463B |
| ASEI | 49.46 | +1.29 | +2.68% | 441.18M |
